Terns Pharmaceuticals
Leadership Board of Directors Our Culture In Memoriam
Our Approach Scientific Publications
Pipeline Our Programs Expanded Access
OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION SEC FILINGS CORPORATE GOVERNANCE EMAIL ALERTS
Scroll
 

Taking the journey towards comprehensive treatment of SERIOUS DISEASE

 
 

RECENT NEWS

OUR THERAPEUTIC PROGRAMS

We are a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases including oncology and obesity.